483 Fougera Pharmaceuticals Nov 2012

483 Fougera Pharmaceuticals Nov 2012

Robert Horan FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued 1 inspectional observation (via FDA 483) on 16 Nov 2012.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 1
  • Inspection end: 16 Nov 2012
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart